Welcome to the e-CCO Library!

P318: Safety of Biological Therapies in Elderly IBD: a Systematic Review and Meta-analysis
Year: 2022
Source: ECCO'22
Authors: Drügg Hahn, G.(1);Golovics, P.(1);Wetwittayakhlang, P.(1);Santa Maria, D.(2);Britto, U.(2);Wild, G.(1);Afif, W.(1);Bessissow, T.(1);Bitton, A.(1);LakatosPhD, P.L.(1);
Created: Friday, 11 February 2022, 3:52 PM
P318: Ustekinumab: early experience and medium-term outcomes from a UK multi-centre real-world cohort
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Gadhok*1, R. Rao1, S. Honap2, M. Samaan3, L. Harpham-Lockyer3, H. Kwok3, L. Whitley3, A. Ibarra1, N. Burgess1, E. Seward3, G. Parkes1, S. Mehta3, R. Vega3, S. McCartney3, S. Bloom3, P. Irving2, J. O. Lindsay1, K. Kok1, F. Rahman3

Created: Friday, 22 February 2019, 9:41 AM
P319 Clinical characteristics of patients with inflammatory bowel disease and metabolic syndrome
Year: 2020
Source:

ECCO'20 Vienna

Authors:

I.V. Gubonina, V. Grinevich, M. Poluektov, T. Kolodin, S. Lapteva, A. Gamzaeva, N. Gubonina, MMA-IBD Group

Created: Thursday, 30 January 2020, 10:12 AM
P319: Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Vázquez-Morόn J.M.*1, Benítez-Rodríguez B.2, Pallarés-Manrique H.1, Machancoses F.H.3, Robles Rodríguez J.L.4, Ramos-Lora M.1, Ruíz-Frutos C.5

Created: Wednesday, 20 February 2019, 10:36 AM
P319: Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kobayashi, T.(1)*;Dignass, A.(2);Roblin, X.(3);Fujitani, Y.(4);Oortwijn, A.(5);Jamoul, C.(6);Hibi, T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P319: Combining anti-inflammatory treatment with antiviral treatment in severe cytomegalovirus-positive ulcerative colitis does not affect colectomy rate: a retrospective European multicentre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

U. Kopylov*1, K. Papamichael2, 3, K. Katsanos4, M. Waterman5, A. Bar-Gil Shitrit6, T. Boysen7, F. Portela8, A. Peixoto9, A. Szilagyi10, M. Silva9, G. Maconi11, O. Har-Noy1, P. Bossuyt12, G. Mantzaris2, M. Barreiro de Acosta13, M. Chaparro14, D. Christodoulou4, R. Eliakim1, J.-F. Rahier15, F. Magro9, S. Ben-Horin16, X. Roblin17

Created: Friday, 22 February 2019, 9:49 AM
P319: Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU
Year: 2021
Source: ECCO'21 Virtual
Authors: García García, M.J.(1);Rivero, M.(1);Miranda-Bautista, J.(2);Bastón-Rey, I.(3);Mesonero, F.(4);Leo-Carnerero, E.(5);Casas-Deza, D.(6);Cagigas Fernández, C.(7);Martin-Cardona, A.(8);El Hajra, I.(9);Hernández-Aretxabaleta, N.(10);Pérez-Martínez, I.(11);Fuentes-Valenzuela, E.(12);Jiménez, N.(13);Rubín de Célix, C.(14);Gutiérrez, A.(15);Suárez Ferrer, C.(16);Huguet, J.M.(17);Fernández-Clotet, A.(18);González-Vivó, M.(19);Del Val, B.(20);Castro-Poceiro, J.(21);Melcarne, L.(22);Dueñas, C.(23);Izquierdo, M.(24);Monfort, D.(25);Bouhmidi, A.(26);Ramírez De la Piscina, P.(27);Romero, E.(28);Molina, G.(29);Zorrilla , J.(30);Calvino-Suárez, C.(3);Sánchez, E.(4);Nuñez, A.(5);Sierra, O.(6);Castro, B.(1);Zabana, Y.(8);González-Partida, I.(9);Chaparro, M.(14);Gisbert, J.P.(14);
Created: Wednesday, 2 June 2021, 4:12 PM
P319: Incorporating HLADQA1*05 in pre-biologic screening in IBD patients initiating biologic therapies
Year: 2022
Source: ECCO'22
Authors: Aleman Gonzalez, H.(1);Ramachandran, S.(1);Whitehead, E.(1);Pattinson, A.(1);Stamp, K.(1);Turnbull, J.(1);Myers, S.(1);Talbot, A.(1);Sebastian, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P319: Long-term outcomes after anti-TNF therapy withdrawal in patients with radiologically healed perianal Crohn’s fistulas
Year: 2018
Source: ECCO '18 Vienna
Authors:

W.Y. Mak1*, S. Adegbola2, K. Sahnan2, P. Tozer2, P. Lung2, A. Hart2, S.C. Ng3

Created: Thursday, 21 February 2019, 9:14 AM
P319: Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on adalimumab maintenance therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. H. Oh*1, A-R. Yoon2, S. H. Park3, J. Kim1, N. Ham1, E. M. Song1, S. W. Hwang1,2, S. H. Park1,2, D-H. Yang1, J-S. Byeon1, S-J. Myung1, S-K. Yang1,2, B. D. Ye1,2

Created: Friday, 22 February 2019, 9:41 AM
P320 Thrombocytosis in acute inflammatory bowel disease: a useful biomarker?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Gazelakis1, I. Chu1, C. Martin2, M. Ward1,3, M. Sparrow1,3

Created: Thursday, 30 January 2020, 10:12 AM
P320: 6-Thioguanine nucleotide levels are associated with trough levels of infliximab and adalimumab in Inflammatory Bowel Disease patients on combination therapy: A retrospective multicentre study
Year: 2022
Source: ECCO'22
Authors: Yu, N.(1);Tassone, D.(1);Lee, T.(1);Phan, S.(2);Wu, D.M.(2);Tjahyadi, J.(3);Dutt, K.(3);Liou, H.(4);Wang, L.(5);Zhang, J.(6);Basnayake, C.(1,7);Wright, E.(1,7);Lust, M.(1);Niewiadomski, O.(1);Kamm, M.A.(1,7);Connell, W.(1);Thompson, A.(1,7);Hilmi, I.(8);Affendi Raja Ali, R.(9);Wei, S.C.(4);De Cruz, P.(2,7);van Langenberg, D.(3,10);Moore, G.T.(5,10);Friedman, A.B.(6);Ding, N.S.(1,7);
Created: Friday, 11 February 2022, 3:52 PM
P320: Accuracy of faecal calprotectin level to select patients with inflammatory bowel disease for a chromoendoscopy surveillance programme
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.L. De Castro1*, A. Lopez-Martínez2, R. Fernandez-Victoria3, L. Sanromán1, J.R. Pineda1, V. Hernández1, J. Martínez-Cadilla1, M. Figueira1, S. Pereira1, I. Rodríguez-Prada1

Created: Thursday, 21 February 2019, 9:14 AM
P320: Clinical and economic effect of short infliximab infusion protocol in patients with inflammatory bowel diseases: a multicentre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Cappello*1, G. Costantino2, A.C. Privitera3, F. Bossa4, A. Lauria5, L. Grossi6, M. B. Principi7, N. Della Valle8, M. A. Veneziano9, D. Crocchiolo9

Created: Friday, 22 February 2019, 9:49 AM
P320: Combined mesenchymal stromal cells and anti-cytokine therapy of perianal Crohn's disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Knyazev, O.(1,2,3);Kagramanova, A.V.(1);Lishchinskaya, A.(1);Shkurko, T.(4);Li, I.(1);Parfenov, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P320: Confocal Laser Endomicroscopy to predict the efficacy of vedolizumab as first-line biotherapy in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Quénéhervé, L.(1);Trang-Poisson, C.(2);Fantou, A.(3);Flamant, M.(4);Durand, T.(5);Bouguen, G.(6);Bregeon, J.(7);Oullier, T.(7);Amil, M.(8);Dewitte, M.(6);Bardot, S.(9);Braudeau, C.(10);Josien, R.(3);Neunlist, M.(7);Bourreille, A.(11)*;
Created: Friday, 14 July 2023, 11:05 AM
P320: High Cytomegalovirus DNA load in mucosal biopsies predicts steroid failure as well as colectomy in acute severe ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Jain1, D. Namdeo1, S. Kedia1, P. Sahu1, P. Das1, P. Sahni1, N. R. Dash1, S. Pal1, G. Makharia1, L. Dar1, V. Ahuja*1

Created: Friday, 22 February 2019, 9:41 AM
P320: Utility of a semi-quantitative rapid test in diagnosis of ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Dranga M.*1, Mihai C.1, Gavrilescu O.1, Ungureanu I.1, Cucuteanu B.2, Cijevschi-Prelipcean C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P321 Prognosis of intestinal Behcet’s disease according to the Korean consensus-based diagnostic algorithm
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y.Y. JOO, B.I. Lee, S.J. Kim, H.H. Lee, J.S. Kim, J.M. Park, Y.S. Cho, K.M. Lee, S.W. Kim, H. Choi, M.G. Choi

Created: Thursday, 30 January 2020, 10:12 AM
P321: Activity graph patterns recorded using a mobile monitoring system are associated with clinical outcomes of patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kim E.S.*1, Jang B.I.2, Kim K.O.2, Kim E.Y.3, Lee H.S.1, Kwak S.G.4, Lee E.Y.1, Lee Y.J.5 Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD)

Created: Wednesday, 20 February 2019, 10:36 AM